Global Pharmaceuticals & Biotech Buy the Dip

Summit Therapeutics

Market Cap: US$13.2b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Corcept Therapeutics

Market Cap: US$7.4b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Hvsen Biotechnology

Market Cap: CN¥4.6b

Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.

Eton Pharmaceuticals

Market Cap: US$505.2m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Kilitch Drugs (India)

Market Cap: ₹6.9b

Engages in the development and operation of pharmaceutical business in India.

Relief Therapeutics Holding

Market Cap: CHF 29.5m

A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally.

Coral Laboratories

Market Cap: ₹2.2b

Manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

Alpa Laboratories

Market Cap: ₹2.1b

Engages in the manufacture and sale of pharmaceutical finished dosage forms in India.

PeterLabs Holdings Berhad

Market Cap: RM 90.8m

An investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally.

SOL Global Investments

Market Cap: CA$13.3m

A private equity firm specializing in growth capital to small and mid-sized businesses.